Full Paper
multiplet, High-resolution mass spectra were recorded on
a
141.03, 140.90, 137.40, 136.92, 134.74, 134.31, 132.22, 131.16,
129.04, 128.20, 128.06, 127.92, 127.10, 123.90, 123.17, 54.65, 52.50,
51.87, 51.44, 23.90, 23.89, 21.30, 20.32, 20.27, 16.33, 11.15 ppm;
11B NMR (128 MHz, C6D6): d=À6.32 ppm; HREI-MS: calcd for
C34H36BNO4S [M]+: 565.2458; found: 565.2473.
Thermo Fisher Scientific MALDI LTQ Orbitrap XL mass spectrome-
ter. Exact masses were calculated based on the predominant com-
bination of natural isotopes. Photoisomerization reactions of all
compounds were performed in sealed J-Young NMR tubes using a
Rayonet photochemical reactor at 298 K. UV/Vis spectra were re-
corded on a Varian Cary 50 spectrophotometer.
Synthesis of 3b: Compound 3 was synthesized according to a pre-
vious literature procedure.[5c] Compound 3 (4.0 mg, 9 mmol) was
solubilized in C6D6 (0.51 mL, c=0.017m) and irradiated with UV
light at 300 nm for 3 h to fully convert it into 3a. DMAD (0.1 mL,
0.82 mmol) was then added to the reaction mixture in a single por-
tion. After heating in an oil bath at 308C for 2 h, the clear light-
yellow solution containing the product was concentrated in vacuo
and purified by column chromatography on neutral alumina elut-
ing with hexanes/ethyl acetate (9:1), affording a light-yellow resi-
due of 3b. Crystals of 3b were grown by slow evaporation of the
volatiles from a concentrated solution in hexanes/dichloromethane
(9:1) and washed with hexanes to afford the pure compound
Synthesis and characterization
Synthesis of 1b: Compound 1 was synthesized according to a pre-
vious literature procedure.[5a] 1 (15 mg, 37 mmol) was dissolved in
C6D6 (0.90 mL, c=0.04m) and irradiated at ambient temperature
with UV lamps at 365 nm for 8 h to fully convert colourless 1 into
dark-blue 1a, as monitored by 1H NMR spectrometry. DMAD
(0.1 mL, 0.82 mmol) was then added in a single portion to the solu-
tion of 1a. After heating overnight in an oil bath at 308C, the solu-
tion turned yellow and NMR spectra indicated nearly quantitative
formation of 1b. The clear yellow solution containing the product
was concentrated in vacuo and purified by column chromatogra-
phy on neutral alumina eluting with hexanes/ethyl acetate (9:1), af-
fording a yellow-orange residue. Crystals of 1b were grown by
slow evaporation of the volatiles from a concentrated solution in
hexanes/ethyl acetate (5:1) and subsequently washed with hexanes
1
(4.4 mg, 84%). H NMR (700 MHz, C6D6): d=9.39 (d, J=8.0 Hz, 1H;
o-Cbz-H), 7.68 (d, J=8.0 Hz, 1H), 7.65–7.61 (m, 1H; CBz-N-(Ph)C=
CÀH), 7.61 (t, J=8.0 Hz, 1H; m-3-Cbz-H), 7.05 (t, J=8.5 Hz, 1H; p-
CBz-H, overlapped with a C6D6 satellite peak), 6.85 (s, 1H; Mes-H),
6.84–6.80 (m, 2H; BzIm-H), 6.73 (s, 1H; Mes-H), 6.44–6.40 (m, 1H;
CH3-N-(Ph)C=CÀH), 5.27 (t, J=2.0 Hz, 1H; cyclohexene-sp2-CÀH),
4.43 (d, J=2.2 Hz, 1H; cyclohexene-sp3-CÀH), 3.60 (s, 3H; -OCH3),
3.41 (s, 3H; -OCH3), 2.75 (s, 3H; o-Mes-CH3), 2.49 (s, 3H; N-CH3),
2.29 (s, 3H; p-Mes-CH3), 2.00 (s, 3H; cyclohexene-CH3), 1.86 (s, 3H;
o-Mes-6-CH3), 1.49 (d, 4J=1.59, 3H; allylic CH3), 0.88 ppm (s, 3H;
BCC-CH3); 13C NMR (176 MHz, C6D6): d=170.01, 165.91, 162.37,
150.67, 145.78, 142.71, 141.30, 137.18, 136.60, 136.60, 135.58,
133.70, 132.71, 132.37, 130.18, 128.45, 128.20, 128.06, 127.92,
126.13, 124.14, 123.74, 123.09, 118.67, 114.45, 110.28, 56.46, 53.63,
51.87, 51.44, 31.50, 30.23, 24.86, 23.75, 21.91, 21.31, 20.70,
19.76 ppm; 11B NMR (225 MHz, C6D6): d=À15.96 ppm; HREI-MS:
calcd for C38H39BN2O4 [M]+: 598.3003; found: 598.3001.
1
to afford the pure product (19 mg, 93%). H NMR (400 MHz, C6D6):
d=9.19 (d, J=8.3 Hz, 1H; o-Cbz-H), 8.18 (dd, J=6.5, 1.7 Hz, 1H; o-
Py-H), 7.64 (t, J=7.5 Hz, 1H; m-3-Cbz-H), 7.58 (d, J=8.2 Hz, 1H; m-
5-Cbz-H), 7.39 (d, J=8.5 Hz, 1H; m-5-Py-H), 6.99 (t, J=7.6 Hz, 1H;
p-Cbz-H, overlapped with Mes-H), 6.95 (s, 1H; Mes-H, overlapped
with p-Cbz-H), 6.82 (s, 1H; Mes-H), 6.56 (td, J=8.3 Hz, 1.6 Hz, 1H;
p-Py-H), 5.88 (t, J=6.8 Hz, 1H; m-3-Py-H), 5.18 (s, 1H; cyclohexene-
sp2-CÀH), 4.42 (d, 4J=2.0 Hz, 1H; cyclohexene-sp3-CÀH), 3.60 (s,
3H; -OCH3), 3.38 (s, 3H; -OCH3), 2.66 (s, 3H; o-Mes-2-CH3), 2.27 (s,
3H; p-Mes-CH3), 2.10 (s, 3H; o-Mes-6-CH3), 2.07 (s, 3H; cyclohex-
ene-CH3), 1.52 (d, 4J=1.06 Hz, 3H; allylic CH3), 0.62 ppm (s, 3H;
BCC-CH3); 13C NMR (126 MHz, C6D6): d=169.49, 165.57, 160.24,
151.70, 148.61, 147.82, 147.61, 145.80, 145.64, 141.40, 140.24,
137.12, 136.20, 134.33, 131.61, 130.39, 127.98, 127.88, 127.69,
127.49, 126.28, 125.78, 122.94, 120.95, 119.93, 54.80, 52.52, 51.47,
51.04, 29.88, 23.68, 23.16, 20.92, 20.56, 20.05, 16.58 ppm; 11B NMR
(128 MHz, C6D6): d=À5.77 ppm; HREI-MS: calcd for C35H36BNO4
[M]+: 545.2737; found: 545.2738.
Synthesis of 1c: Compound 1a (8.8 mg, 21.8 mmol, 30 mm, 0.5 mL
of C6D6) was generated in the same manner as described for the
synthesis of 1b. Maleic anhydride (2.20 mg, 22 mmol) was added to
the reaction mixture in a single portion. After 24 h at room tem-
perature, the clear yellow solution was concentrated in vacuo and
then extracted with hexanes to afford a yellow residue of 1c. Crys-
tals of 1c were grown by slow evaporation of the solvent from a
concentrated solution in hexanes and washed with cold hexanes
Synthesis of 2b: Compound 2 was synthesized according to a pre-
vious literature report.[5b] 2 (22 mg, 51 mmol) was dissolved in C6D6
(2 mL, c=0.025m) and irradiated with UV light at 365 nm for
7 days to fully convert it into 2a. DMAD (0.1 mL, 0.82 mmol) was
then added in a single portion to the solution of 2a. After heating
overnight in an oil bath at 308C, the clear yellow solution contain-
ing the product was concentrated in vacuo and purified by
column chromatography on neutral alumina eluting with hexanes/
ethyl acetate (9:1), affording a yellow residue of 2b. Crystals of 2b
were grown by slow evaporation of the volatiles from a concen-
trated solution in hexanes/ethyl acetate (5:1) and washed with
hexanes to afford the pure compound (28 mg, 94%). 1H NMR
(700 MHz, C6D6): d=9.23 (d, J=8.5 Hz, 1H; o-Cbz-H), 7.56 (td, J=
7.8, 7.2, 1.3 Hz, 1H; m-3-Cbz-H), 7.49 (dd, J=7.8, 1.1 Hz, 1H; m-5-
Cbz-H), 6.95 (s, 1H; Mes-H), 6.86 (t, J=7.5 Hz, 1H; p-CBz-H), 6.84 (s,
1H; Mes-H), 6.75 (d, J=1.4 Hz, 1H; thiazole-H), 5.28 (t, J=2.0 Hz,
1H; cyclohexene-sp2-CÀH), 4.45 (d, J=2.2 Hz, 1H; cyclohexene-sp3-
CÀH), 3.62 (s, 3H; -OCH3), 3.38 (s, 3H; -OCH3), 2.66 (s, 3H; o-Mes-
2-), 2.27 (s, 3H; p-Mes-CH3), 2.16 (s, 3H; o-Mes-6-CH3), 2.08 (s, 3H;
1
to afford the pure compound (42%). H NMR (700 MHz, C6D6): d=
8.10 (d, J=6.4 Hz, 1H; o-Py-H), 7.96 (d, J=8.4 Hz, 1H; o-Cbz-H),
7.67 (d, J=8.2 Hz, 1H; m-5-Cbz-H), 7.43 (d, J=8.6 Hz, 1H; m-5-Py-
H), 7.29–7.26 (m, 1H; m-2-Cbz-H), 7.01 (t, J=7.6 Hz, 1H; p-Cbz-H),
6.88 (s, 1H; Mes-H), 6.75 (s, 1H; Mes-H), 6.57 (t, J=7.8 Hz, 1H; p-
Py-H), 5.89 (t, J=6.8 Hz, 1H; m-2-Py-H), 4.82 (t, J=1.9 Hz, 1H; cy-
clohexene-sp2-CÀH), 3.63 (d, J=8.1 Hz, 1H; exo-H), 3.23 (t, J=
2.6 Hz, 1H; cyclohexene-sp3-CÀH), 2.81 (dd, J=8.1, 3.2 Hz, 1H; exo-
H), 2.37 (s, 3H; o-Mes-CH3), 2.24 (s, 3H; p-Mes-CH3), 2.16 (s, 3H; cy-
clohexene-CH3), 1.87 (s, 3H; o-Mes-CH3), 1.46 (d, J=1.6 Hz, 3H; al-
lylic CH3), 0.05 ppm (s, 3H; BCC-CH3); 13C NMR (176 MHz, C6D6): d=
173.95, 173.09, 146.02, 145.51, 141.75, 140.21, 139.54, 136.07,
136.01, 135.14, 130.17, 129.96, 128.59, 128.20, 128.06, 127.92,
127.41, 122.62, 121.16, 120.45, 49.92, 49.09, 44.32, 43.36, 23.64,
23.56, 23.30, 21.83, 21.23, 13.97 ppm; 11B NMR (225 MHz, C6D6): d=
À8.70 ppm; HRESI-MS: calcd for C33H32BNO3 [M+1]: 502.2548;
found: 502.2536.
4
4
cyclohexene-CH3), 1.42 (d, J=1.7 Hz, 3H; allylic CH3), 1.16 (d, J=
1.2 Hz, 3H; thiazole-CH3), 0.59 ppm (s, 3H; BCC-CH3); 13C NMR
(176 MHz, C6D6): d =169.90, 165.83, 162.79, 159.64, 148.53, 147.59,
&
&
Chem. Eur. J. 2019, 25, 1 – 8
6
ꢀ 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!